Synta Pharmaceuticals Up 24.1% Since SmarTrend Uptrend Call (SNTA)
SmarTrend identified an Uptrend for Synta Pharmaceuticals (NASDAQ:SNTA) on December 11th, 2012 at $8.44. In approximately 1 month, Synta Pharmaceuticals has returned 24.05% as of today's recent price of $10.47.
Over the past year, Synta Pharmaceuticals has traded in a range of $3.57 to $10.57 and is now at $10.47, 193% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has risen 1.3%.
Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Synta Pharmaceuticals shares.
Log in and add Synta Pharmaceuticals (SNTA) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Keywords: spotlights synta pharmaceuticals